Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Veterinary Organoid-on-Chip System Development

Inquiry Now
Background of Veterinary Organoid Chips Microfluidic Chip Design and Development 3D Structure and Sensor Integration Applications of Veterinary Organoid-on-Chip System Advantages of Veterinary Organoid-on-Chip Technology Related Research Why Choose Us? Case Study FAQs

BioVenic provides veterinary organoid-on-chip system development services that integrate organoid engineering with microfluidic technology to design and build customized organ-chip models, supporting veterinary drug development, disease model construction, and developmental biology research. Our platform covers microfluidic chip design and development to mimic in vivo organ physiology and microenvironment, 3D structure and sensor integration (cell layers or matrices replicating target-organ architecture, with real-time monitoring of oxygen, pH, and temperature), and customized veterinary organoid chip fabrication across various animal organs and tissues. We support applications in high-throughput veterinary drug screening, personalized tumor and rare-disease modeling, and companion-animal cell therapy research through systematic solutions integrating chip materials, surface design, mechanical dynamics, sensors, and high-throughput detection.

Fig.1 Organoids-on-a-chip platform application in pancreatic islet research. (Yin, et al., 2022)Fig. 1 The application of organoids-on-a-chip platform in pancreatic islet research.1,2

Background of Veterinary Organoid Chips

In research related to the development of animal therapies, the advent of organoids has broadened the field. Organoids are miniature "organs" induced and cultured in vitro by stem cells that can partially reproduce the physiological functions of organs. Organ chips are miniature structures formed by the combination of microfluidic devices and living cells that can reproduce the physiological and pathological characteristics of organs in vivo in vitro. Organoid chips combine the advantages of both approaches. In the development of precision therapies for animal tumors, organoid models offer cost effectiveness and high efficiency. In veterinary drug discovery and development, organoids can serve as efficient models for high-throughput screening in animal tumors and rare diseases. Currently, the use of organoids in the development of cell therapy and veterinary drugs for companion animals is beginning to attract the attention of scientists, while organoid chips are still in the early stages of development.

Veterinary Organoid-on-Chip System Development Services

BioVenic collaborates with researchers to tackle various challenges in the development of veterinary organoid chip systems. We are committed to providing scientific and effective support through our expertise and research resources. Our microfluidic chip R&D team addresses scientific research issues for clients throughout crucial stages of organoid chip preparation, including cell inoculation, functional 3D structure formation, chip design, and sensor integration.

Microfluidic Chip Design and Development

BioVenic combines fundamental theory and project experience in cell biology, organoids and microfluidic chip development. We are dedicated to developing chips that mimic the physiological conditions and microenvironment of animal organs in vivo and accurately reproduce them in vitro.

3D Structure and Sensor Integration

BioVenic specializes in in vitro 3D culture of animal cells and integrates this with organoid chip development technology. Our expert team replicates the 3D structure of the target organ by utilizing various cell layers or appropriate matrices to mimic the organ's extracellular matrix. Our team is incorporating sensors into the development of veterinary organoid chips to enable real-time monitoring of key parameters such as oxygen levels, pH and temperature, making it easier to assess the health and functionality of the organoid.

Applications of Veterinary Organoid-on-Chip System

Developmental Biology Organoid chip system supports the construction of an in vitro animal developmental research model that accurately simulates the tissue structure of the target organ and the interaction between multiple organs.
Disease Model Construction Culturing tumor cells or induced pluripotent stem cells from diseased animals on organoid chips has great potential in constructing specific disease models, thereby enabling the development of personalized therapy.
Veterinary Drug Development Organoid chips offer the advantages of high throughput, seamless integration and reproducibility. They simulate the structure and physiological processes of different organs in a bionic microenvironment, replicating the interactions and crosstalk between organs and facilitating more complex and physiologically relevant research in veterinary drug development.

Advantages of Veterinary Organoid-on-Chip Technology

  • By integrating microfluidics technology, more accurate and controllable organoid model construction can be achieved. This technology can help control and simulate the microenvironment, vascularization, and interaction between tissues, thereby assisting in high-throughput analysis of organoid models.
  • Organoid chips combine the advantages of medical biology and engineering. They can not only realize 3D cell culture and reproduce the relationships between cells and between cells and the matrix, but also simulate important in vivo microenvironments such as interstitial fluid and mechanical force stimulation of target organs in the body.
  • Through real-time imaging, sensors, and other technologies, organoid chips offer unparalleled advantages in studying individual animal genetic development, disease occurrence and development mechanisms, veterinary drug screening, and immune evaluation in bionic microenvironments.
  • Organoid chips are small in size and have multiple culture chambers, making them suitable for simultaneous multi-group control experiments. This greatly reduces individual differences and experimental cycles, enabling the study of single organoids and providing a strong argument for preclinical research.

Related Research

A previous literature establishes an integrative framework for organ-on-a-chip (OoC) microphysiological systems by systematically linking stem cell-derived organoid engineering, biofabrication, dynamic fluidic control, and computational analytics. Methodologically, the work details the complete experimental pipeline, encompassing organoid derivation, matrix scaffolds, microfabrication techniques (such as soft lithography, micro-milling, and 3D printing in polydimethylsiloxane or thermoplastics), dynamic perfusion design, and the integration of mechanical, electrochemical, and optical sensors with artificial intelligence-driven data acquisition. Key scientific findings emphasize that compartmentalized microchannel architectures and continuous fluid shear stress overcome the architectural, gradient, and maturation limitations of conventional 2D cultures and static 3D spheroids. Furthermore, the biophysical advantages of these biomimetic microfluidic environments lie in their capacity to establish physiologically relevant tissue-tissue interfaces, recreate organ-organ crosstalk (e.g., ADME modeling), and enhance tissue fidelity and functional reproducibility, thereby offering a standardized microphysiological roadmap for translational human and comparative veterinary biomedical research.

Fig. 2 The fabrication of organ-on-chip devices. (Surina, 2025) (OA Literature)Fig. 2 The fabrication of organ-on-chip (OoC) devices.3

Why Choose Us?

Cross-field Joint Development

Veterinary organoid chips combine the engineering advantages of organoids and microfluidic chips. Our scientific research provides reliable knowledge in both areas.

Systematic Solution Design

Our systematic solution combines chip materials, surface design, mechanical dynamics, sensors and high-throughput detection to provide customized solutions for the development of veterinary organoid chips that can have multiple applications.

Strict Quality Control System

We are equipped with standardized quality control procedures in animal stem cell culture, differentiation and in vitro organoid research technology to ensure the steps in veterinary organoid-on-a-chip development.

Case Study

Researchers developed a veterinary organoid-on-chip system that couples a custom microfluidic chip with 3D organoid culture and integrated sensors for real-time monitoring. Compared with conventional static culture, the on-chip system scored higher across every functional dimension—microenvironment control, physiological relevance, real-time monitoring, reproducibility, high-throughput capacity, and barrier integrity—providing a more organ-like platform for drug response prediction and disease modeling in animals.

vFig. 3 Case Study

Frequently Asked Questions

Q1: What veterinary species and tissue/organ types can be supported for Organoid-on-Chip development?

A: Our systems accommodate various tissue models such as gut-on-a-chip, liver-on-a-chip, lung-on-a-chip, and skin-on-a-chip. Because physiological specifications and primary tissue isolation requirements vary significantly by species and organ target, custom microfluidic designs may be tailored to your study goals. For specific species feasibility, organ models, or customized chip architecture requests, please contact our technical support team for a detailed consultation.

Q2: What are the sample requirements and submission guidelines for primary tissue or organoid sourcing?

A: For optimal viability, primary tissue biopsies or pre-established organoid cultures should be collected and shipped according to strict temperature and preservation protocols. Detailed criteria—such as tissue weight, transport buffer recipes, and cold-chain shipping arrangements—depend on the animal species and primary cell sensitivity. We strongly advise consulting our technical support team before sampling to receive customized sample preparation protocols and shipping instructions.

Q3: How do Organoid-on-Chip systems compare to traditional 2D cell cultures or standard 3D organoid static cultures?

A: Traditional 2D cell cultures and static 3D organoids lack mechanical cues and dynamic fluid movement, which limits their physiological relevance. Veterinary Organoid-on-Chip systems integrate microfluidic flow, mechanical shear stress, and cell-cell fluidic interactions, replicating the complex microenvironment, tissue barriers, and vascularization observed in vivo. This provides a more accurate predictive platform for veterinary drug screening, pathogen-host interaction studies, and toxicity testing without relying heavily on live animal models.

BioVenic has established a highly professional scientific research team specializing in cytology and biomedical engineering. The team possesses a strong innovative spirit and expertise in animal cell therapy and veterinary drug development. We integrate cutting-edge technologies and top-tier talents from various high-precision biological sectors, including organoid engineering, 3D cell culture, microfluidic chip development and preparation, and high-throughput detection platforms. Our commitment is to consistently deliver high-quality solutions to our customers. If you are interested in BioVenic's veterinary organ-on-a-chip research solutions, please contact us with your research interests and we will be happy to discuss further with you.

References

  1. Image retrieved from Figure 1 "The application of organoids-on-a-chip platform in pancreatic islet research." Yin et al., 2022, used under CC BY 4.0. Without modification.
  2. Yin, Jiaxiang, et al. "Pancreatic islet organoids-on-a-chip: how far have we gone?" Journal of Nanobiotechnology 20.1 (2022): 308. https://doi.org/10.1186/s12951-022-01518-2.
  3. Surina, Surina, et al. "Organ-on-a-chip: a roadmap for translational research in human and veterinary medicine." International Journal of Molecular Sciences 26.21 (2025): 10753. https://doi.org/10.3390/ijms262110753. Used under CC BY 4.0. Without modification.
Inquiry Basket
Advertisement